These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32082273)

  • 21. [BCG vaccines for the prevention of tuberculosis in the world].
    Hashimoto T
    Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.
    Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ
    PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the development of vaccines for tuberculosis.
    Ahsan MJ
    Ther Adv Vaccines; 2015 May; 3(3):66-75. PubMed ID: 26288734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.
    Penn-Nicholson A; Geldenhuys H; Burny W; van der Most R; Day CL; Jongert E; Moris P; Hatherill M; Ofori-Anyinam O; Hanekom W; ; Bollaerts A; Demoitie MA; Kany Luabeya AK; De Ruymaeker E; Tameris M; Lapierre D; Scriba TJ
    Vaccine; 2015 Jul; 33(32):4025-34. PubMed ID: 26072017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New vaccines against tuberculosis].
    Kaufmann SHE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):56-64. PubMed ID: 31784764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.
    Boggiano C; Eichelberg K; Ramachandra L; Shea J; Ramakrishnan L; Behar S; Ernst JD; Porcelli SA; Maeurer M; Kornfeld H
    Vaccine; 2017 Jun; 35(27):3433-3440. PubMed ID: 28476627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis vaccine: A journey from BCG to present.
    Fatima S; Kumari A; Das G; Dwivedi VP
    Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing tuberculosis vaccine efficacy trials - lessons from recent studies.
    Ginsberg AM
    Expert Rev Vaccines; 2019 May; 18(5):423-432. PubMed ID: 30892969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel vaccination approaches to prevent tuberculosis in children.
    Triccas JA; Counoupas C
    Pneumonia (Nathan); 2016; 8():18. PubMed ID: 28702297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis vaccines: Opportunities and challenges.
    Zhu B; Dockrell HM; Ottenhoff THM; Evans TG; Zhang Y
    Respirology; 2018 Apr; 23(4):359-368. PubMed ID: 29341430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.
    Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A
    Front Immunol; 2018; 9():308. PubMed ID: 29535713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the bacille Calmette-Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine.
    Cohn DL
    Am J Med Sci; 1997 Jun; 313(6):372-6. PubMed ID: 9186153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine strategies for the
    Sharan R; Kaushal D
    NPJ Vaccines; 2020; 5():95. PubMed ID: 33083030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing vaccine-mediated protection in an ultra-low dose
    Plumlee CR; Barrett HW; Shao DE; Lien KA; Cross LM; Cohen SB; Edlefsen PT; Urdahl KB
    bioRxiv; 2023 Jun; ():. PubMed ID: 36993415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis vaccine development at a divide.
    Kaufmann SH
    Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4
    Sathkumara HD; Pai S; Aceves-Sánchez MJ; Ketheesan N; Flores-Valdez MA; Kupz A
    Front Immunol; 2019; 10():532. PubMed ID: 30949177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.